June 17, 2002
Avoiding insulin injections would greatly improve quality of life for many diabetics, and new products presented on June 15 and 16 at the American Diabetic Association annual meeting promise to do exactly that.
These include insulin in transdermal, oral pills, oral spray, and pulmonary inhaled forms. “Studies are underway to develop a convenient 24-hour insulin patch to provide painless, needle-free, basal insulin delivery for people with diabetes,” write Alan M. Smith and colleagues. “Basal insulin infusion has been achieved using a transdermal patch containing an unmodified approved insulin formulation without the use of chemical enhancers, iontophoresis or ultrasound.”
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!